3.64
3.70%
-0.14
Finanzdaten der AbCellera Biologics Inc-Aktie (ABCL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
39.10%
9.179
|
6.599 | 10.06 | 12.19 | 21.55 |
Operating Expenses
|
22.35%
75.23
|
61.49 | 61.45 | 77.07 | 59.32 |
Benefits Costs and Expenses |
25.95%
57.78
|
45.88 | 48.06 | 60.34 | 52.96 |
Costs And Expenses |
25.95%
57.78
|
45.88 | 48.06 | 60.34 | 52.96 |
Depreciation and Amortization |
31.40%
7.536
|
5.735 | 5.61 | 5.514 | - |
Operating Income/Loss |
20.34%
-66.05
|
-54.89 | -51.39 | -64.87 | -37.78 |
Nonoperating Income/Loss |
11.77%
17.45
|
15.61 | 13.38 | 16.73 | 6.366 |
Income/Loss From Continuing Operations Before Tax |
23.74%
-48.60
|
-39.28 | -38.00 | -48.15 | -31.41 |
Income Tax Expense/Benefit |
86.39%
-1.452
|
-10.67 | -7.476 | -8.038 | -1.519 |
Income/Loss From Continuing Operations After Tax |
64.80%
-47.15
|
-28.61 | -30.53 | -40.11 | -29.89 |
Net Income/Loss
|
64.80%
-47.15
|
-28.61 | -30.53 | -40.11 | -29.89 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.86%
0.4161
|
289.50 | 288.91 | 287.77 | 0.417 |
Diluted Average Shares |
99.86%
0.4161
|
289.50 | 288.91 | 287.77 | 0.6433 |
Basic Earnings Per Share |
70.00%
-0.17
|
-0.10 | -0.11 | -0.14 | -0.10 |
Diluted Earnings Per Share |
70.00%
-0.17
|
-0.10 | -0.11 | -0.14 | -0.10 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):